These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6028364)

  • 1. [Limitations of prolonged extrarenal hemodialysis in patients with terminal chronic uremia].
    Casciani C
    Minerva Med; 1967 Jun; 58(45):2096-7. PubMed ID: 6028364
    [No Abstract]   [Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Terminal uremia in patients on regular hemodialysis].
    Ermolenko VM
    Ter Arkh; 1974; 46(7):84-93. PubMed ID: 4411106
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of terminal-stage uremia by substitution dialysis methods in France in December 1981].
    Jacobs C; Patte R
    Nephrologie; 1983; 4(2):64-8. PubMed ID: 6877480
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the management of chronic uremia. 3. Role of hemodialysis in the management of chronic uremia].
    Villarreal H
    Gac Med Mex; 1967 Dec; 97(12):1604-8. PubMed ID: 5611802
    [No Abstract]   [Full Text] [Related]  

  • 6. Terminal uremia and arteriovenous fistula patency.
    Iuchtman M; Jacob ET; Boner G; Weiner P
    Int Surg; 1981; 66(3):241-2. PubMed ID: 7319737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of intraocular pressure during hemodialysis in patients with chronic uremia].
    Biagini M; Gloria EM
    Ann Ottalmol Clin Ocul; 1967 Jul; 93(7):705-13. PubMed ID: 5605002
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modification of the reaction capacity of chronic uremia patients through hemodialysis].
    Raabe H; Buchali K; Precht K; Schulz W
    Z Urol Nephrol; 1975 Mar; 68(3):181-5. PubMed ID: 1227187
    [No Abstract]   [Full Text] [Related]  

  • 9. [Calculation of the DMF index in a patient population with terminal uremia undergoing periodic hemodialysis].
    Calabrese L; Cervelli A; Taccone Gallucci M; Calabrese C; Tozzo C; Giorgetti G
    Dent Cadmos; 1984 Oct; 52(10 Suppl):89, 92-3. PubMed ID: 6598774
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of uremia with chronic hemodialysis.
    Sadler JH
    J Med Assoc Ga; 1966 Nov; 55(11):484. PubMed ID: 5978853
    [No Abstract]   [Full Text] [Related]  

  • 11. [The visual apparatus in chronic uremia treated with periodic hemodialysis. IV. Exophthalmometric changes during hemodialysis].
    Esposito E; Tufano L; Fortunato G; Sorice PS; Ambrosio A
    Rass Int Clin Ter; 1971 Sep; 51(17):1072-5. PubMed ID: 5132750
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodialysis in the treatment of arterial hypertension in terminal uremia].
    Romagnoli GF; Saporiti E; Naso A; Lorenzi S; Cerutti M; Di Landro D; Perin N; Bertoli M; Huber W
    G Clin Med; 1977; 58(3-4):108-22. PubMed ID: 913927
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodialysis for chronic uremia in Arizona, past, present and future.
    Johnson KE; Potter DJ
    Ariz Med; 1967 Jun; 24(6):531-5. PubMed ID: 6046012
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current views on the effectiveness of hemodialysis in the treatment of chronic uremia].
    Segoloni G; Ragni R; Stratta P; Triolo G; Giachino G; Piccoli G
    Arch Sci Med (Torino); 1971; 128(4):175-80. PubMed ID: 5154430
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis.
    Ylikorkala O; Huttunen K; Järvi J; Viinikka L
    Clin Nephrol; 1982 Aug; 18(2):83-7. PubMed ID: 6754193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proposal for a differentiated hemolytic treatment in chronic uremia].
    Vercellone A; Piccoli G; Martini PF; Mangiarotti C; Giachino G; Fruttero B; Quarello F
    G Clin Med; 1973 Oct; 54(10):644-65. PubMed ID: 4789298
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical physiopathological aspects of chronic uremia under hemodialysis].
    Vercellone A
    Minerva Nefrol; 1972; 19(2):48-9. PubMed ID: 4681260
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of hemodialysis on the levels of zinc in chronic uremia].
    De Sancho JL; Montenegro J; Ruíz De Gauna R; Gómez-Ullate P; García Damborenea R
    Rev Clin Esp; 1980 Feb; 156(3):179-81. PubMed ID: 7367711
    [No Abstract]   [Full Text] [Related]  

  • 19. [The excretion of ascorbic acid and its metabolites in uremia and hemodialysis].
    Bakaev VV; Efremov AV
    Patol Fiziol Eksp Ter; 2000; (2):22-4. PubMed ID: 10846906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron supplementation and oxidative stress in patients with uremia.
    Shetty JK; Prakash M
    Indian J Physiol Pharmacol; 2007; 51(2):179-82. PubMed ID: 18175664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.